Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (391-400 of 438) with videos related to

Pageof 44
Sort By:
Molecular Cancer Therapeutics|May 2, 2006
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitorDaniel H Albert, Paul Tapang, Terrance J Magoc, et al.
Blood|April 26, 2024
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunitySu Han Lum, Michael H Albert, Patrick Gilbert, et al.
Journal of Clinical Immunology|March 14, 2026
Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening ProgramLea Graafen, Carsten Speckmann, Shahrzad Bakhtiar, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2017
Methylpyrrole inhibitors of BET bromodomainsLisa A Hasvold, George S Sheppard, Le Wang, et al.
Journal of Medicinal Chemistry|September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitorsYujia Dai, Yan Guo, Robin R Frey, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2024
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party studyChristo Tsilifis, Carsten Speckmann, Su Han Lum, et al.
Blood|June 11, 2011
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studyDaniele Moratto, Silvia Giliani, Carmem Bonfim, et al.
Journal of Clinical Immunology|February 27, 2023
Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)Carsten Speckmann, Uta Nennstiel, Manfred Hönig, et al.
Molecular Cancer Therapeutics|July 13, 2021
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid LeukemiaLu Zhang, Tianyu Cai, Xiaoyu Lin, et al.
Journal of Medicinal Chemistry|April 12, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channelJürgen Dinges, Daniel H Albert, Lee D Arnold, et al.
Pageof 44

Showing results (391-400 of 438) with videos related to

Sort By:
Pageof 44
Molecular Cancer Therapeutics|May 2, 2006
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitorDaniel H Albert, Paul Tapang, Terrance J Magoc, et al.
Blood|April 26, 2024
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunitySu Han Lum, Michael H Albert, Patrick Gilbert, et al.
Journal of Clinical Immunology|March 14, 2026
Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening ProgramLea Graafen, Carsten Speckmann, Shahrzad Bakhtiar, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2017
Methylpyrrole inhibitors of BET bromodomainsLisa A Hasvold, George S Sheppard, Le Wang, et al.
Journal of Medicinal Chemistry|September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitorsYujia Dai, Yan Guo, Robin R Frey, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2024
Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party studyChristo Tsilifis, Carsten Speckmann, Su Han Lum, et al.
Blood|June 11, 2011
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studyDaniele Moratto, Silvia Giliani, Carmem Bonfim, et al.
Journal of Clinical Immunology|February 27, 2023
Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)Carsten Speckmann, Uta Nennstiel, Manfred Hönig, et al.
Molecular Cancer Therapeutics|July 13, 2021
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid LeukemiaLu Zhang, Tianyu Cai, Xiaoyu Lin, et al.
Journal of Medicinal Chemistry|April 12, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channelJürgen Dinges, Daniel H Albert, Lee D Arnold, et al.
Pageof 44